The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 29-year-old woman was referred to Tufts Medical Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results